Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

NCT02002325 is registered in ClinicalTrials.gov with National Cerebral and Cardiovascular Center, Japan as lead sponsor.

NCT NCT02002325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02002325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
Lead sponsor
National Cerebral and Cardiovascular Center, Japan
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2014
Completion date
March 31, 2020
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke